NAFDAC Director-General, Prof. Mojisola Adeyeye, has returned to Nigeria after spending 34 years in the United States, stating her goal is to restore the country’s reputation in food and drug safety. She has rejected calls for her resignation, emphasizing her commitment to addressing the ongoing challenges in the sector. Adeyeye’s return comes amid growing concerns over the proliferation of counterfeit products, which have become a major public health issue.
In recent statements, NAFDAC has pointed to Chinese dealers operating within Nigeria as key contributors to the counterfeit crisis. Director of Investigation and Enforcement, Martins Iluyomade, highlighted the role of these dealers in the illegal production and distribution of harmful goods. The agency has been working to strengthen enforcement and improve regulatory oversight to combat the spread of fake products.
The counterfeit drug problem has led to numerous health risks and has undermined public trust in local pharmaceuticals. NAFDAC is now focusing on increased inspections, stricter penalties for violators, and greater collaboration with international partners to trace and intercept illegal imports. The agency’s efforts are seen as critical in restoring consumer confidence and ensuring safer medical supplies across the country.
NAFDAC’s renewed focus on enforcement and transparency is expected to have a significant impact on the pharmaceutical landscape in Nigeria. The agency remains under pressure to deliver tangible results as the counterfeit crisis continues to affect millions of Nigerians.
